We have located links that may give you full text access.
Radiation exposure to general public after permanent brachytherapy for prostate cancer.
Radiation Protection Dosimetry 2011 July
Permanent prostate brachytherapy patients are generally told to limit their time around children and pregnant women. However, there is little data available to validate the instruction. For the skin effective dose rate, ion chamber survey meter model 451B-DE-SI was used. The meter was scanned at the point of 4.5, 20, 50 and 100 cm from the skin surface in each plane. Life time exposure was calculated from the average anterior data. At the point of 4.5 cm from the anterior skin surface, the lifetime equivalent dose was 46.5 mSv, at 20 cm it was 13.2 mSv, at 50 cm it was 3.5 mSv and at 100 cm it was 0.9 mSv. The risk from the prostate brachytherapy patients to general public is quite low. Only the case of close and long-time contact with the pregnant and the infant should be paid attention to.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app